Nieuws
Apply now to present at Innovation for Health & Global Investor Forum 2019!
Do you want to raise capital or to find partners to co-develop your healthcare solution? Then pitch your company at the next edition of Innovation for Health and Global Investor Forum on 14 February 2019. The organisation is looking for 10 start-up and 6 scale-up companies, particularly young and innovative companies active in Life Sciences, medical technology, e-health, pharma and diagnostics. The conference brings together over 800 key players in Life Sciences & Health, providing a great opportunity for entrepreneurs and CEOs to get exposure amongst many leading investors, potential partners, future customers, other key stakeholders and opinion leaders.
Patients, doctors, scientists and financiers join forces in Dutch CardioVascular Alliance
Overvallen worden door een hartinfarct of een beroerte behoort over ruim 10 jaar tot het verleden. Die ambitie stelt de Dutch CardioVascular Alliance (DCVA) zich, een nieuw samenwerkingsverband van twaalf organisaties, wetenschappers en zorgprofessionals op het gebied van hart- en vaatonderzoek. De DCVA werd vandaag feestelijk gelanceerd tijdens een presentatie in het Muntgebouw in Utrecht.
MIND presents Knowledge Agenda
Er wordt regelmatig wetenschappelijk onderzoek gedaan naar psychische aandoeningen. Maar nog te weinig naar facetten die volgens ggz-cliënten en naasten veel meer impact kunnen hebben: denk aan het effect van langdurig gebruik van psychofarmaca op de gezondheid, of de relatie tussen leefstijl en een psychische aandoening. De agenda is tot stand gekomen door MIND i.s.m. SiRM en een panel van ervaringsdeskundige cliënten, familieleden en naasten.
New publication our immune system: a guardian, mediator, and betrayer
The new publication by Biosciences and Society (Biowetenschappen en Maatschappij) explains all about our immune system and how it can guards, mediates or betrays us. The interesting patient perspectives on autoimmune diseases brings the story of the immune system to life.
Health~Holland opens call for Organ-on-Chip showcases
The Top Sector Life Sciences & Health and hDMT join forces on the research and development of organ-on-chip technology. This field of technology offers our society and healthcare system great opportunities to treat chronic diseases in a personalized way. In addition, the technology can lead to the reduction of animal experiments by development of alternative preclinical test models. To enhance the R&D and develop organ-on-chip showcases the Top Sector and hDMT established the new Health~Holland Organ-on-Chip Showcases (HHOOCS) programme.
Health~Holland introduce the Innovation Broker in collaboration with MedtechPartners
MedtechPartners and Health~Holland introduce a new tool to support start-ups and SMEs. The new tool, called Innovation Broker, provides guidance for companies for their innovation process, the development of a business case or support with market introduction. A great tool to get access to specialised consultative support to help grow your business.Survey on new journalistic platform for life sciences
Onderzoeksbureau Motivaction onderzoekt of er behoefte bestaat aan een onafhankelijk journalistiek medium dat zich speciaal richt op mensen die werken in of met biotech, medtech, farma en e-health.
FDA approves first-of-its kind targeted RNA-based therapy
The FDA approved Alnylam's patisiran for the treatment of peripheral nerve disease (polyneuropathy), caused by hereditary transthyretin-mediated amyloidosis (hATTR). It is the first FDA approval of a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.
Big Data & Health call open for application
Gezamenlijk met NWO, ZonMw, de Hartstichting, ministerie VWS en het Netherlands eScience Center, Topsector ICT en Creatieve Industrie lanceert de Top Sector LSH (Health~Holland) het PPS-onderzoeksprogramma Big Data & Gezondhheid. Dit programma is nu open voor aanvragen.
Open call for Oncode investigator applications
Oncode Institute has opened a call for applications for their Oncode Recruitment Programme. Up to eleven scientists will be awarded base-funding for the remaining duration of the first phase of Oncode, ending in September 2022.